Clinical Trial Update: Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD [NA]

View source ↗

Summary

This trial update reports the completion of a study evaluating the effect of the probiotic L. lactis CKDB001 on liver aminotransferase levels in adults with non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• L. lactis CKDB001 (Lactococcus lactis CKDB001)

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Non Alcoholic Fatty Liver Disease | NA | Status: COMPLETED